O’Melveny & Myers and Jingtian & Gongcheng have advised Chinese medical device company Peijia Medical on its HK$2.34 billion ($302 million) IPO on the Hong Kong Stock Exchange, with Herbert Smith Freehills and Commerce & Finance Law Offices representing the underwriters.

This was the third healthcare company to list in Hong Kong since the coronavirus outbreak in late January. Also advising Peijia were Campbells Law Firm, Hengtai Law Offices, and Guangdong Junlong Law Firm

Peijia Medical is a medical devices provider of heart and neurovascular diseases equipment specifically offering services for Chinese patients and healthcare providers.

The Herbert Smith team was led by partners Matt Emsley, Siddhartha Sivaramakrishnan and Stanley Xie.

To contact the editorial team, please email ALBEditor@thomsonreuters.com.